BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 21556660)

  • 21. Role of p53 and apoptosis in carcinogenesis.
    Wang XW
    Anticancer Res; 1999; 19(6A):4759-71. PubMed ID: 10697590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 in breast cancer subtypes and new insights into response to chemotherapy.
    Bertheau P; Lehmann-Che J; Varna M; Dumay A; Poirot B; Porcher R; Turpin E; Plassa LF; de Roquancourt A; Bourstyn E; de Cremoux P; Janin A; Giacchetti S; Espié M; de Thé H
    Breast; 2013 Aug; 22 Suppl 2():S27-9. PubMed ID: 24074787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment.
    Harris CC
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):435-9. PubMed ID: 8781359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of the p53 tumor-suppressor gene in clinical oncology.
    Chang F; Syrjänen S; Syrjänen K
    J Clin Oncol; 1995 Apr; 13(4):1009-22. PubMed ID: 7707100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of tumor suppressor genes in bladder cancer.
    Cordon-Cardo C; Reuter VE
    Semin Diagn Pathol; 1997 May; 14(2):123-32. PubMed ID: 9179973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does a p53 "Wild-type" Immunophenotype Exclude a Diagnosis of Endometrial Serous Carcinoma?
    Fadare O; Roma AA; Parkash V; Zheng W; Walavalkar V
    Adv Anat Pathol; 2018 Jan; 25(1):61-70. PubMed ID: 28945609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The p53 gene and protein in bronchial carcinogenesis:from biological to clinical aspects].
    Zalcman G; Trédaniel J; Lechapt E; Lubin R; Soussi T; Hirsch A
    Rev Mal Respir; 1994; 11(5):455-72. PubMed ID: 7816989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein p53--structure, function, and possible therapeutic implications.
    Batinac T; Gruber F; Lipozencić J; Zamolo-Koncar G; Stasić A; Brajac I
    Acta Dermatovenerol Croat; 2003 Dec; 11(4):225-30. PubMed ID: 14670223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes.
    Yokota J; Sugimura T
    FASEB J; 1993 Jul; 7(10):920-5. PubMed ID: 8344488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic targeting of tumor suppressor genes.
    Morris LG; Chan TA
    Cancer; 2015 May; 121(9):1357-68. PubMed ID: 25557041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the biological activities of wild-type and mutant p53.
    Zambetti GP; Levine AJ
    FASEB J; 1993 Jul; 7(10):855-65. PubMed ID: 8344485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
    Chang F; Syrjänen S; Kurvinen K; Syrjänen K
    Am J Gastroenterol; 1993 Feb; 88(2):174-86. PubMed ID: 8424417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 tumor-suppressor gene: clues to molecular carcinogenesis.
    Wang XW; Harris CC
    J Cell Physiol; 1997 Nov; 173(2):247-55. PubMed ID: 9365531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of proto-oncogene activation in carcinogenesis.
    Anderson MW; Reynolds SH; You M; Maronpot RM
    Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular basis of multistage carcinogenesis.
    Harris CC
    Princess Takamatsu Symp; 1991; 22():3-19. PubMed ID: 1844248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [p53 as a molecular target for cancer therapy].
    Ishioka C; Osada M; Gamo M; Kanamaru R
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2207-12. PubMed ID: 9422063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bladder cancer. I. Molecular and genetic basis of carcinogenesis.
    Brandau S; Böhle A
    Eur Urol; 2001 May; 39(5):491-7. PubMed ID: 11464028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical implications of p53 alterations in oral cancer progression: a review from India.
    Patel KR; Vajaria BN; Singh RD; Begum R; Patel PS
    Exp Oncol; 2018 Mar; 40(1):10-18. PubMed ID: 29600984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 and apoptosis.
    Bellamy CO
    Br Med Bull; 1997; 53(3):522-38. PubMed ID: 9374035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.